China toughens disease law

In the wake of SARS, a revised law ensures funding for infectious disease control

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

International observers reacted with cautious optimism this week to news that China's parliament has beefed up its main infectious disease and control law, warning that the law needs to be properly implemented for it to have the desired effect.

"The new legislation sounds sensible–although the devil is always in the detail," said Vivian Lin, head of the School of Public Health, La Trobe University in Australia, and an expert of public health in China.

"From a Western perspective, we'd always be looking for an appropriate balance between coercive powers to protect the public and protection of individual liberties–privacy, autonomy, and confidentiality," she told The Scientist. "It's important to have reserve powers, but how they are exercised and delegated and scrutinized are important."

The Standing Committee of China's National People's Congress responded to last year's SARS outbreaks by passing a revision of the country's Law on the Prevention and Control of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Paul Mooney

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development